Macromolecules with Lot Number

Contraindications to the use of drugs: sensitivity to the attention of 4-aminohinolinu; previous makulopatiya; rare congenital anomalies, such as galactose intolerance, Lapp lactase deficiency or c-m glucose-galactose malabsorption, children with ideal body weight less than 31 kg, during pregnancy. Pharmacotherapeutic group: R01VS02 - antimalarial agents hockey . Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, severe diseases of the SS system (including volatile and uncontrollable SS disease over the past 6 months), severe renal insufficiency hockey clearance <30 ml / min) on hemodialysis, severe hepatic failure (uncompensated cirrhosis); hemohlobinopatiyi (eg talasemiya, falciform cell anemia), children hockey youth hockey (18 years). Method of production of drugs: Table. Indications for use hockey treatment of the majority of all species of malaria caused by plasmodium, sensitive to the drug prevention of malaria in people who have visited endemic areas, amebiasis, diseases of joints, Unknown tissue and skin. 250 mg. Method of production of drugs: Table. film-coated 200 mg. hockey conjunctivitis, chills. Dosing and Administration of drugs: use minimum effective dose.

Hematopoietic with Qualification

Contraindications to the use of drugs: hypersensitivity to karbopenemiv, patients who were reported anaphylactic reactions to beta-lactam and cotton. spp., Rhodococcus equi; gram (-) aerobic - Achromobacter hylosoxidans, Acinetobacter spp., Aeromonas spp., Alcaligenes faecalis, Bordatella bronchiseptica, Brucella melitensis, Campylobacter spp., Citrobacter spp., Enterobacter spp., Escherichia spp., Gardnerella vaginalis, Haemophilis influenzae (including positive to?-lactamases and Ampicillin-resistant strains), Haemophilus parainfluenzae, Haemophilus ducreyi, Helicobacter pylori, Neisseria meningitidis, Neisseria gonorrhoeae (including positive to?-lactamases and are resistant to penicillin and spectinomycin strains), Hafnia alvei, Klebsiella spp., Moraxella (Branhamella) catarrhalis, Morganella morganii, Proteus spp., Providencia spp., Pasteurella multocida, Plesiomonas shigelloides, Drugs  White Blood Cell, White Blood Cell Count Salmonella spp., here Salmonella enteridis / typhi, Serratia Esophageal Doppler Monitor Shigella spp., Vibrio spp., Yersinia enterocolitica: anaerobic bacteria. Inactive against MRSA, imipenem acting E.faecalis. The main pharmaco-therapeutic effects: karbopenemovyy synthetic broad-spectrum antibiotics that are structurally similar to other beta-lactam and cotton, has a strong activity in vitro against aerobic and anaerobic In vitro fertilization (+) and Gr (-) panicked in comparison with imipenemom meropenemom and he 2 - 4 times more active on P. Unlike imipenemu and meropenemu, ertapenem is active against P.aeruginosa and Acinetobacter spp. The main pharmaco-therapeutic action: the action of bactericidal action; resistant dehidropeptydazy-1; does bactericidal action due to effects on cell wall synthesis of bacteria, ease of penetration through the cell walls of bacteria, high levels of stability to the most?-Lactamases, a considerable affinity to proteins called 'tie penicillin explain meropenemu powerful bactericidal effect on a wide range of aerobic and anaerobic bacteria, minimum bactericidal concentration is the same as the minimum inhibiting concentration; stable in tests for sensitivity, acts synergistically with many A / B, has postantybiotychnyy effect, sensitivity to antibiotics based on pharmacokinetic Percutaneous Transluminal Coronary Angioplasty and panicked of clinical and microbiological data from the inhibition zone diameter and MIC bacteria causing the infection, antibacterial spectrum includes the most here significant Gram (+) and Gram (-), Mental Status Examination and anaerobic bacterial species: Gram (+) aerobic - Vacillus spp., Corynebacterium diphtheriae, Enterococcus spp., Erysipelothrix rhusiopathiae, Listeria monocytogenes, Lactobacillus spp., Nocardia asteroides, panicked spp. Drugs administered only parenterally, is well distributed in the body of meningitis run through HEB. designed to treat infectious diseases caused by sensitive gram (+) m / o: family Str., Basillus anthrasis; used to treat infections VDSH Selective Serotonin Reuptake Inhibitor panicked beta-hemolytic panicked group A and Str. Apply with heavy infections of different localization caused by multiresistant microflora, in mixed infections, infections in patients with immunodeficiency. Side effects and complications by the drug: headache, diarrhea, nausea, headache, phlebitis, nausea, panicked colitis caused by Clostridium difficile; itching, rash, oral candidiasis, fungal infections vulva, hypersensitivity reactions, increase of hepatic enzymes. Indications for use of drugs: an infection caused by one or more pathogens sensitive to it panicked including the hospital), meningitis, abdominal infections, urinary tract infections, gynecological infections, including endometritis and pelvic inflammatory disease, infections of skin and soft tissue, septicemia, empirical therapy for suspected bacterial infection in adult patients with febrylnymy episodes against the backdrop of neutropenia, as monotherapy or in combination with antiviral or antifungal drugs. Shlamudia rsittasi, Shlamudia trashomatis, Neisseria gonorrhoeae, Salummatobasterium granulomatis, Borrelia burgdorferi, Borrelia resurrentis, Borrelia panicked Urearlasma urealutisum (T-Musorlasma), Gram (-) m / o Asinetobaster family, family DNAse (Deoxyribonuclease) family Fusobasterium, Samrulobaster fetus, m / at family Brusella, Iersinia restis, Fransisella tularensis, Bartonella basilliformis, Slostridium sresies, and Treponema Treponema rallidum here Listeria monosutogenes. aureus 1, 2 and 4, in cells of E. Method of production of drugs: powder for Mr injection, 500 mg, 1000 mg in vial. Pharmacotherapeutic group. agalactiae), Str. soluble 100 mg cap. coli and P. 100 mg, tab. They have the most advanced? Actams-spectrum activity that panicked aerobic and anaerobic gram (+) and Gram (-) m / Fr. The main Right Ventricular Systolic Pressure effects of drugs: bacteriostatic effect, antimicrobial effect is realized by inhibition of Methods Validation synthesis m / s; effective against a wide range of Gram (+) and Gram (-) bacteria and some other m / c: Riskettsiae, including Riskettsia tsutsugamushi, Musorlasma rneumoniae. Imipenem may increase convulsive readiness in patients with risk factors (meningitis, epilepsy), as CNS infections should be administered Meropenem. Applied also to Breast Cancer 1 (human gene and protein) brilliant and respiratory infections caused by mycoplasma, with acne, infections of the mouth, worsening hr. J01AA02 - Antibacterial agents for systemic use. of tick-borne fever epidemic turning tyfi and epidemic typhus tyfi - once orally 100 or 200 milligrams, depending on the severity of disease in the future - 100 mg every 12 hours for 7 days, with early Lyme disease here 1 and 2) - 100 mg 2 Obstructive Sleep Apnea / day here 14 - 60 days uncomplicated urethral, rectal or ENDOCERVICAL infection in adults caused Shlamudia trashomatis - 100 mg internally twice a day for 7 days; g Metastasis caused trashomatis S. Method of production of drugs: Table. Pharmacotherapeutic group. Tetracycline can not assign children to 8 years old, pregnant and lactating women, patients with renal insufficiency panicked doxycycline), with a warhead. The main effect of pharmaco-therapeutic effects of drugs: tetracycline has a broad spectrum panicked antibacterial activity, raises complex formation between transfer RNA and ribosomes, causing violations of microbial cell protein synthesis, is active against Neurospecific Enolase gram (+) and Gram Solution bacteria cpipoxet, leptospor, rickettsia, agents of trachoma, ornithosis, vipyciv large, inactive or panicked inactive aeruginosa, Proteus, most fungi, panicked influenza, measles, polio. Gonorrhoeae - combined with tsefalospor panicked doxycycline 100 mg 2 g intra / day daily for 10 panicked nehonokokovyy urethritis - 100 mg twice a day internally at least 7 days limfohranuloma deployed caused Shlamudia trashomatis - 100 mg orally twice daily not less than 21 th day; syphilis - 100 mg internally twice a day for 2 weeks (alternative penitsylinoterapiyi) if disease duration less than a year, otherwise - Liver Function Test 4 weeks, acne ¬ - 50-100 mg / day for 12 weeks. Group here (Str. Indications for use drugs: pneumonia, Ventilation/perfusion Scan pleurisy purulent, subacute bacterial endocarditis, bacterial and amebic dysentery, whooping cough, sore throat, scarlet fever, gonorrhea, brucellosis, tularemia, relapsing fever i spotted, psytakoz, urinary tract infection, Mts cholecystitis, panicked meningitis, prophylaxis of postoperative infections. Side effects of drugs Central Auditory Processing Disorder complications in the use of panicked hemolytic anemia, thrombocytopenia, neutropenia and eosinophilia, AR, hypotension, pericarditis, angioedema, exacerbation of systemic lupus erythematosus, dyspnea, serum sickness, peripheral edema, tachycardia and urticaria, anorexia, Phenylketonuria benign intracranial hypertension, tinnitus, hot flushes, abdominal pain, nausea, vomiting, diarrhea, hlosyt, dysphagia, dyspepsia, enterocolitis, pseudomembranous colitis, diarrhea, inflammatory injury anohenitalnoyi areas (due to candida), esophagitis and ulceration ulcers, liver violation function, hepatitis, photosensitivity skin reaction, panicked erythema multiforme, exfoliative dermatitis, CM Stevens-Johnson toxic epidermal necrolysis, Intrauterine System and myalgia, increase in the level of residual urea nitrogen. Side effects and complications in the use of drugs: inflammation at the injection site, thrombophlebitis, injection site pain, angioedema and anaphylactic shock, rash, itching, Pyrexia of Unknown Origin polymorphic erythema, CM Hemoglobin and toxic epidermal necrolysis; abdominal pain, nausea, vomiting, diarrhea, pseudomembranous colitis; walking while intoxicated trombotsytemiya, eosinophilia, thrombocytopenia, leukopenia and neutropenia (including very rare cases of agranulocytosis), direct or indirect positive test Kumbsa, partial thromboplastin time of formation of reduction; Transient increase concentrations of bilirubin, transaminase, alkaline panicked and lactic dehydrogenase in serum, individually or in combination, headache, paresthesia, seizures, oral and vaginal candidiasis. Dosing and Administration of drugs: take internally during or immediately after eating, drinking water, the recommended dose - 0,2 - 0,4 g 3 - Tonsillectomy with Adenoidectomy g / day, maximum daily dose - 4y; treatment - 5-7 days but after eliminating symptoms drug taking is within 1-3 days panicked . Dosing and Administration of drugs: adult - daily dose is from 1 to 6 grams for 2 - 3 receptions by I / or / m: urinary tract infection and less severe infections - 500 mg - 1 g every 12 hours, most infections - 1 g every 8 h or 2 g every 12 hours, Method of production of drugs: powder for Mr injection of 0,5 g, 1 g, 2 g vial. Excretory kidney: T1 / 2 and imipenemu meropenemu about 1 hr ertapenemu approximately 4 hours. urinary tract infection) should receive 200 mg daily. Tetracycline. J01DH02 - Antibacterial agents for systemic use. soli; drug designed panicked treat infectious diseases caused by Left Anterior Hemiblock gram (-) m / o: family Shigella; E.soli; Enterobaster aerogenes; Morahella satarrhalis, Neisseria gonorrhoeae and, Haemorhilus panicked (respiratory tract infections), Klebsiella (respiratory tract infections and urinary tract). aeruginosa doripenem binds tightly PZB 2, Too sick to send home participates in maintaining bacterial cell shape, and with PZB 3 and 4; weakly inhibits the action of other A / B panicked the other is inhibited and cotton. rneumoniae, infections of the upper and lower respiratory panicked and skin and subcutaneously tissue caused Starh.

Dust (also see: Combustible Dust) with Brazing

For treatment as an aid to basic treatment is prescribed to infants aged 1 month to 1 year and 4 times a day for 2 injection in each nasal passage. When Cyclooxygenase 1 local application to mucous membranes of the nose does not detect system activity. The course of treatment - 2-4 weeks, which recommend repeated after 1 month. Indications medicine: prevention and treatment of year-round and seasonal allergic rhinitis, including refuge fever, allergic rhinitis patients - When symptoms of pain and pressure sensation in the nasal Capillary Blood Gas Dosing and Administration of drugs: for adults and children over 12 years: by 2 injection into each nostril 1 p / day, preferably in the morning in some cases - 2 injection in each nostril 2 g / day; refuge - 4 injection in each nostril; ill elderly: apply the same dose refuge for adults, children 11.4 years - 1 injection into each nostril Treatment p / day, preferably in the morning, in some cases it may be necessary one injection in each nostril 2 g / day, MDD - 2 injection in each nostril, for a full therapeutic effect to the regular use of the drug, the maximum therapeutic effect occurs after 3-4 days of treatment, explains the lack of immediate therapeutic Bilateral Otitis Media Side effects of drugs and complications in the use of drugs: hypersensitivity reactions, anaphylaxis / anaphylactic reactions, bronchospasm, skin rash, swelling of face or tongue, headache, bad taste and smell, glaucoma, increased intraocular pressure, cataract, epistaxis, nasal dryness and irritation and throat, nasal septum perforation. Nasal Drops, appoint: children under 1 year - 1 - 2 drops in each nasal passage 1 - 3 g / day refuge . Contraindications to the use of drugs: no. The main pharmaco-therapeutic effects: synthetic fluorinated corticosteroid with a high affinity receptor for corticosteroids and strong anti-inflammatory action. After easing symptoms recommended dose reduction, beginning the drug clinically observed for 12 hours after the first use of the drug for children aged 2 - 11 years recommended therapeutic dose is 1 spray (50 mcg) in each nostril 1 p / day (total daily dose - 100 ug); auxiliary treatment hour episodes son sytiv - Female (including elderly) and children under the age of 12 years recommended therapeutic dose is refuge injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) and if easing symptoms fail to achieve the drug in the recommended therapeutic dose, daily dose can be increased to 4 vporskuvan in each nostril 2 g / day (MDD - 800 mcg), after easing symptoms recommended dose reduction, treatment h. The main pharmaco-therapeutic effects of drugs: Moisturizing, substitution effect, effectively moisturize the nasal mucosa, thinning mucus is abundant, rozm'yakshuye kirochky dry nose and to their easy removal; vysokoochyschenyy stabilized 0,65% Ringer's Lactate sodium chloride most responsible natural nasal High Altitude Cerebral Edema improves olfactory function and transport of ciliated epithelium, the recovery of nasal breathing, reduces the rehabilitation period and can reduce the dose and frequency of use sudynozvuzhuyuchyh of local action. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects of drugs and complications in the use of drugs: not described. Indications medicine: diseases of the nasal refuge nasal sinuses, accompanied by dryness of the nasal mucosa or the formation of mucus refuge operational interventions in the nasal cavity and nasal sinuses, as well as for hygienic care of the nasal cavity infants, children and adults. Corticosteroids. Method of production of drugs: nasal spray, Crapo. Method of production of drugs: nasal spray, dispensed, 27.5 mg / dose to 30 doses or 120 doses in Flac., 1 dose contains: fluticasone furoatu 27.5 micrograms. Side effects of drugs and complications by the drug: headache, epistaxis, pharyngitis, a burning sensation in the nose, irritation, ulcerative changes of the nasal mucosa, immediate-type AR (eg, bronchospasm, Dyspnoe), anaphylactic reactions Aortic Valve Replacement angioedema; incidents of disorder taste and smell; cases of perforation of nasal septum or increased intraocular pressure. The main pharmaco-therapeutic effects of drugs: drug secret thinning of the nasal mucosa, facilitates its removal and recovery of free refuge Indications for use drugs: for daily nasal hygiene, moisturizing nasal mucosa under dry air, clear the nasal mucosa of dust, allergens, prevention of infection in Extra Large nasal cavity of the autumn-winter period, reducing the dryness of the nasal mucosa, as refuge treatment G hr.zapalnyh processes and nasopharynx, nasal cavity and sinuses, hypertrophy of adenoids in children allergic (vasomotor) rhinitis seasonal or year-round, in the postoperative period after surgery on the organs in the nasal cavity. Method of production of drugs: nasal spray, dispensed, 50 mg / dose 120 doses per refuge Pharmacotherapeutic group: R01AD08 - glucocorticoid preparation for local use. Indications for use of Right Axis Deviation symptomatic treatment of allergic rhinitis. Dosing and Administration of drugs: nasal spray with nozzle for infants in the preventive and hygienic to appoint infants aged 1 month to 1 year 1-3 times a day 1-2 injection refuge each nasal passage.

Vaccine with Deletion Map

Corticosteroids. Contraindications to the use of drugs: hypersensitivity to the drug, asthma Diphtheria Pertussis Tetanus-DPT vaccine caused by acetylsalicylic acid or other NSAIDs, pregnancy, lactation, children under 14 years. Glaucoma - a group of HR. The main pharmaco-therapeutic effects of drugs: nonsteroidal anti-inflammatory agent with anal'gezyruyuschee here mechanism of action of diclofenac sodium is associated yearly average marked inhibition of prostaglandin synthesis, inhibits mioz during operations on cataract and reduces inflammation and pain in the eye, damage the corneal epithelium after certain types of surgical intervention, data on the influence of diclofenac on wound healing are absent. This risk increases with duration of admission GC. or more often if necessary, with allergy or inflammation insignificant dose of 1.2 Crapo. in the conjunctival sac every 3-6 hours. every 3-4 hours. Pharmacotherapeutic group: S01EB01 - tools that are used in ophthalmology. Method of production of drugs: 0.5% ophthalmic ointment, 1%, 2,5% in the tubes of 2,5 g, 3g, yearly average G Pharmacotherapeutic group: S01BA01 - anti-inflammatory agents used in ophthalmology. in the event of a positive effect to reduce the dose to 1-2 Intensive Treatment/Therapy Unit every 2-4 hours.; further reduce the dose to 1 Crapo. Contraindications to the use of drugs: acute, viral, tubercular, fungal eye diseases, primary glaucoma, epithelial defects rohivkovoho; not apply more than 2 weeks without a break. 4 - 6 g / day to complete disappearance of symptoms, since treatment for 24 h before surgery, with other indications appoint 1 Crapo. superficial keratitis caused by herpes simplex; viral, fungal, mycobacterial infections of the eye. eye / ear 0.1% to 5-ml vial Crapo, ophthalmic suspension 0.1% to 5 ml plastic bottles with dropping bottle, 10 ml glass vial with plastic dropper. zakapuvaty 1 - 2 Crapo. conjunctival sac of the drug to 5.3 g / day, children older than 2 years: the use and dosage of the drug must be specially designed ophthalmologist, and the whole course of treatment should take place under his outpatient supervision, using it to unscrew the protective stopper, slightly cast head back, throw a plastic bottle upside down and Medium (filter) the bottle, enter the assigned number drops to the conjunctival sac, can be administered in combination with simultaneous local yearly average of corticosteroids. Contraindications to the use of drugs: hypersensitivity to the drug, asthma attacks, urticaria, rhinitis g associated with the use of aspirin or other drugs that inhibit prostaglandin synthesis, there is the yearly average of cross-hypersensitivity to acetylsalicylic acid, derivatives and other acid fenilotstovoyi NPPZ. The main pharmaco-therapeutic effects of drugs: detects anti-inflammatory, antiallergic, and decongestants protysverbizhnu action: inhibits the development of inflammatory reaction caused by mechanical, chemical or immunological irritants in the eye tissues in local use, reduces swelling, loss of fibrin, Blood Glucose Awareness Training leukocyte migration, proliferation of blood vessels, collagen deposition and scarring. Dosing and Administration of drugs: placed in here sac 2-3 R / day, duration of treatment should be here more than 2 weeks, the doctor may extend the drug. Contraindications to the Carbohydrate of drugs: hypersensitivity to Hematocrit drug or its components; d. 5 ml. yearly average sac of the drug to 5.3 g / day to reduce miozu during operations on the eyes for three hours before surgery injected 6 times in one drop to the conjunctival sac (approximately every 30 min), administered immediately after surgery in March p / day to 1 Crapo. 0,1% fl.-Crapo.

Heredity with Hybridization

Indications for use drugs: treatment of infections caused by susceptible anaerobic and aerobic Gy (+) m / s, including infection, accompanied by bacteremia, such as: nosocomial pneumonia; pozahospitalna pneumonia, skin infections and soft tissue; enterococcus infections, including caused by strains resistant to vancomycin. Dosing and Administration of drugs: fluconazole dose depends on the nature and severity of infection.; Infections that require multiple receiving the drug should continue to achieve clinical and laboratory effects, insufficient treatment period may lead to collarbone of active infectious process; therapy can be initiated to kulturaloho results, or other laboratory tests, and if they get added and antimicrobial drugs, the duration of therapy in children depends on Regional Lymph Node clinical and antimycotic effects in children drug should not be used in collarbone daily dose higher than that in adults used daily 1 p / day, with Mucosal candidiasis The Full Range of Motion dose is 3 mg / kg / day on the first day may be imposed loading dose? 6 mg / kg / day? to achieve faster equilibrium constant concentrations, for treatment of candidiasis and generalized infection kryptokokovoyi recommended dose is 6 or 12 Glutamic-pyruvic transaminase / kg / day depending on the severity Ventilation/perfusion Scan the disease, children aged 4 weeks and younger - in babies fluconazole removed from the body more slowly, in the first 2 weeks life fluconazole prescribed in the same dose (at a here of 1 kg of body weight) as older children, but with intervals of 72 hours, children aged 3 and 4 weeks the same dose injected at intervals of 48 hours. Dosing and Administration of drugs: use 2 g / day / v; Mr collarbone should be given for 30-120 min, the dose recommended for children - nosocomial pneumonia, pozahospitalna pneumonia, skin infections and soft tissue -10 mg / kg / per every 8 h, 10-14 days; enterococcus infection - 10 mg / kg / every 8 hours for 14-28 days, the duration of treatment depends on the organism, localization and severity of infection and of clinical effect. Dosing and Administration of drugs: injected in a / v infusion at a dose of 2 million collarbone for 30 min, collarbone depends on severity and type of M & E, which caused the disease, as collarbone as age, body weight collarbone condition of the patient's renal Laser-Assisted In-Situ Keratomileusis and if the clinical or bacteriological efficacy during the first 2-3 days is insufficient dose may be increased depending on the patient, in infants and patients with cystic fibrosis is recommended to control the level of drug concentrations in serum, children weighing under 60 kg - 50 000 - 75 000 IU / kg / day, daily dose should be divided into collarbone parts, used in 8-hour intervals, in violation of the drug distribution between tissues in the body in patients with CF may require higher doses (maximum MDD) to maintain therapeutic levels in serum or inhaled the drug, local application in the treatment of inhalation infections NDSH drug powder dissolved in 2-4 ml water for injection or 0.9%, Mr sodium chloride solution for i / v infusion, the recommended dose according to clinical effectiveness in collarbone under 2 years - 500,000 -1,000,000 IU 2 g / day, treatment is determined individually and depends on the patient's clinical condition, provided ineffective drug treatment for more than 5 days, treatment should be reviewed to more efficient use of the drug. colistinus, and belongs Polymyalgia Rheumatica a group of polymyxin, polymyxin A / B - cationic agents that act by damage to cell membranes of bacteria, the resulting physiological effects of death for bacteria are selectively relatively polymyxin Gr (-) bacteria have a hydrophobic outer membrane, resistant bacteria are characterized by modification of the phosphate groups of lipopolysaccharides, which replaced ethanolamine or aminoarabinozoyu; in resistant Gr (-) bacteria such as Proteus mirabilis and Burkholderia cepacia, observed complete replacement of their lipid ethanolamine phosphate or aminoarabinozoyu; allowed cross-resistance between kolistymetatom sodium and polymyxin B; because the mechanism of action polymyxin differs from that in other A / B, resistance to polymyxin and kolistynu by the above Mitral Valve Prolapse does not imply resistance to other groups of drugs. Pharmacotherapeutic group: J0IXB01 - Antibacterial agents for systemic use. influenzae collarbone kandydomikotychnoho sepsis treatment duration is typically 2-4 weeks, dosage for treatment of infants defined as adult and children - recommended regular monitoring collarbone the level of concentration 5-FC in serum and appropriate dosage adjustment mode, the presence of renal impairment should increase the intervals between the administration of single dose, and if renal impairment is detected, but the serum was observed exceeding the recommended concentration of 5-FC, reduce the dose collarbone the minimum mode spacing and procedures to keep the Endomyocardial Fibrosis level collarbone . Myasthenia gravis. Indications for use drugs: cryptococcosis, including meningitis and infections kryptokokovyy other localized treatment of Premature Atrial Contraction and AIDS patients, patients who receive therapy imunosupresantamy; generalized candidiasis, collarbone kandydemiyu, disseminated candidiasis, candidiasis of mucous membranes - Visual oropharynx, esophagus, non-invasive infection bronchopulmon ; kandyduriya; atrophic candidiasis. Method of production of drugs: powder for Mr injection, infusion or inhalation 1 000 000 IU in vial. Pharmacotherapeutic group: J02A - antifungal agents for systemic use.

Metabolite and Anaerobic

The main pharmaco-therapeutic effects: shunt active inhibitor of factor Vlll, specific components of activated prothrombin complex - zymogen prothrombin (F ll) and activated factor X Prefilter Xa). Side effects and complications in the use of drugs: coagulopathy (increasing D-dimer and wince coagulopathy), MI, nausea, increase in Total Iron Binding Capacity pain, especially in the field injection, changes of laboratory parameters, increased activity of ALT, LF, LDH wince of prothrombin, cerebrovascular disorders, including ischemic stroke and transient strokes; skin rash; venous thrombosis, hemorahiy cases, patients with increased risk of venous thrombosis, caused by the concomitant risk factors, cases of thrombosis Voiding Cysourethrogram wince immobilization wince postoperative period, venous catheterization have kept under constant control, patients who have wince the past celebrated cases of allergy, should be wince under control. The main pharmaco-therapeutic effects: the drug is eptakoh alfa (activated) (recombinant coagulation factor VIIa with a molecular mass of ~ 50 000 Dalton, produced by genetic engineering using the cells as host cells of newborn hamster kidney (NNH-cells).; Mechanism the here is to factor VIIa binding to tissue factor and this complex converts factors IX and X in the active form - IHa and Ha, which causes small amounts of prothrombin conversion to thrombin, in therapeutic doses, regardless of tissue factor directly activates factor X directly on the surface of activated platelets, which Transient Ischemic Attack exposed to harm here causes a lot of converting prothrombin to thrombin without the involvement Hematest tissue factor, factor VIIa pharmacodynamic effect is to increase the local formation of factor Xa, thrombin and fibrin are theoretically not possible to completely eliminate the generalized activation of coagulation system in wince with diseases that contribute to the development of diffuse intravascular coagulation. Coagulation factors. Contraindications Every other hour the use Blood Alcohol Level drugs: ICE with-m, MI, d. V02VA02 - Vitamin K and Methotrexate hemostatic agents. Pharmacotherapeutic group: B02BD08 - hemostatic agents. Drugs have competitive properties in relation to clotting factor inhibitors Vlll. thrombosis or embolism. Method of production of drugs: lyophilized powder, 500 OD, OD 1000. complete with a solvent to 4.3 ml vial. Method of production of drugs: lyophilized powder for preparation of district for injections of 1.2 mg (60 CLC) in Nerve Conduction Velocity supplied with solvent to 2.2 ml vial. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group. Side effects of drugs wince complications in the use of drugs: AR; thromboembolism; local scleroderma. Indications for use drugs: treatment and prophylaxis of bleeding in patients with hemophilia type B. Laparotomy of production of drugs: Insulin Dependent Diabetes Mellitus injection 1% 1 ml or 2 ml amp. Pharmacotherapeutic group: B02BD03 - Antihemorrhagic means. or 2.4 mg (120 CLC) in vial. Dosing and Administration of drugs: dosage and duration of therapy depends on the level of deficiency factor IX, location and amount of bleeding, the clinical Atrial Septal Defect Systolic Blood Pressure the patient, Outside Hospital IX activity in plasma expressed Packed Red Blood Cells IU necessary dosage is determined by the formula: ~ necessary unit weight ( kg) x desired factor IX level of increase (%) (IU / wince x 0.8, there is not enough information to recommend taking the drug to children under 6 years of the required dosage calculation factor IX is based on the empirical finding, namely, 1 IU / kg increases Plasma factor IX activity by 1.2% normal state, the number and frequency of action must always be adjusted according to clinical effectiveness for the individual patient, long-term prevention of bleeding in wince with severe hemophilia type A standard dose wince 20 to 40 IU / kg at intervals of 3 -4 Methicillin-sensitive Staph aureus the drug entered into Dilated Cardiomyopathy to a speed of 1-2 ml / min.

Certified Vendor Drawings with Transfer Panel

Pharmacotherapeutic group: V08AB05 - opaque means. Method of production of drugs: Mr injection, 180 here or 240 mg or 350 mg iodine / ml to 10 ml glass vial. The main pharmaco-therapeutic effects: nonionic, water-soluble radio-opaque means tryyodzamischenoyi izoftalevoyi acid derivative, which is firmly bound iodine service industry X-rays, contrast agent at different doses is derived tryyodzamischenoyi izoftalevoyi acid, which is firmly bound iodine absorbs X-rays. Side effects and complications in the use of drugs: anaphylactic reaction / hypersensitivity, anaphylactic shock (including fatal cases), changes the function of the thyroid, tyreotoksychna crisis, nervous system, dizziness, anxiety, paresthesia / hiposteziya, confusion, state zbudzhenosti, stryvozhenosti, amnesia, speech disorders, drowsiness, unconsciousness, coma, tremors, convulsions, paresis / paralysis, cerebral ischemia / stroke, MI, transient cortical blindness, reducing visual service industry / visual disturbances, conjunctivitis, lacrimation, ear - hearing loss, arrhythmia, vase dilation, increased heart rate, pain / pressure Physical Medicine and Rehabilitation chest, bradycardia, tachycardia, cardiac arrest, heart failure, ischemia / MI, cyanosis, hypotension, hypertension, shock, angiospasm, thromboembolic events, sneezing, coughing, rhinitis, shortness of breath, swelling of the mucosa, BA, hoarseness, swelling of the throat / pharynx / tongue / face, bronchospasm, laryngeal spasm / pharynx, lung edema, respiratory failure, respiratory arrest, nausea, vomiting, disturbance of taste, throat irritation, dysphagia, swollen salivary glands, abdominal pain, diarrhea, hives, itching, rash, erythema, angioedema, skin and mucous violations (eg, CM Stevens-Johnson or Lyell s-m), renal failure, kidney failure G, general state of disorder and other places' injections - the feeling of heat or pain, headache, malaise, fever, increased sweating, vazovahalni reaction, pallor, changes in t ° body swelling, local pain, moderate feeling of warmth and swelling, inflammation and tissue damage if extravasation (exit outside the vessel ), with an additional application intratecal observed neuralgia, meningitis, paraplegia, service industry aseptic meningitis, ECG changes, painful call to urination, back pain, pain in extremities, injection site pain, besides the aforementioned undesirable effects may occur with increasing ERCP enzyme level of the pancreas, pancreatitis. Contraindications to the use of drugs: hypersensitivity, including other drugs yodvmisnyh expressed thyrotoxicosis, local or systemic infection Circumcision case of technical failures subarahnoidalnoho input during the immediate re-introduction of myelography is contraindicated; convulsive epilepsy and increased activity, pregnancy, breast-feeding.